American Research & Management Company’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $31K | Hold |
950
| – | – | 0.01% | 224 |
|
|
2022
Q2 | $37K | Hold |
950
| – | – | 0.01% | 211 |
|
|
2022
Q1 | $66K | Hold |
950
| – | – | 0.01% | 193 |
|
|
2021
Q4 | $74K | Hold |
950
| – | – | 0.02% | 189 |
|
|
2021
Q3 | $91K | Hold |
950
| – | – | 0.02% | 170 |
|
|
2021
Q2 | $118K | Hold |
950
| – | – | 0.03% | 160 |
|
|
2021
Q1 | $125K | Hold |
950
| – | – | 0.03% | 148 |
|
|
2020
Q4 | $126K | Hold |
950
| – | – | 0.03% | 147 |
|
|
2020
Q3 | $97K | Hold |
950
| – | – | 0.03% | 144 |
|
|
2020
Q2 | $83K | Hold |
950
| – | – | 0.03% | 155 |
|
|
2020
Q1 | $55K | Buy |
950
+50
| +6% | +$4.06K | 0.02% | 171 |
|
|
2019
Q4 | $83K | Hold |
900
| – | – | 0.02% | 164 |
|
|
2019
Q3 | $81K | Hold |
900
| – | – | 0.02% | 168 |
|
|
2019
Q2 | $106K | Hold |
900
| – | – | 0.03% | 160 |
|
|
2019
Q1 | $78K | Hold |
900
| – | – | 0.02% | 185 |
|
|
2018
Q4 | $57K | Hold |
900
| – | – | 0.02% | 172 |
|
|
2018
Q3 | $71K | Hold |
900
| – | – | 0.02% | 174 |
|
|
2018
Q2 | $54K | Sell |
900
-100
| -10% | -$5.38K | 0.02% | 167 |
|
|
2018
Q1 | $40K | Hold |
1,000
| – | – | 0.01% | 198 |
|
|
2017
Q4 | $53K | Sell |
1,000
-300
| -23% | -$16K | 0.02% | 185 |
|
|
2017
Q3 | $61K | Sell |
1,300
-150
| -10% | -$6.04K | 0.02% | 162 |
|
|
2017
Q2 | $51K | Sell |
1,450
-200
| -12% | -$6.17K | 0.02% | 171 |
|
|
2017
Q1 | $39K | Sell |
1,650
-500
| -23% | -$9.91K | 0.01% | 179 |
|
|
2016
Q4 | $29K | Sell |
2,150
-200
| -9% | -$3.23K | 0.01% | 209 |
|
|
2016
Q3 | $44K | Sell |
2,350
-500
| -18% | -$8.81K | 0.02% | 186 |
|
|
2016
Q2 | $35K | Hold |
2,850
| – | – | 0.01% | 189 |
|
|
2016
Q1 | $19K | Hold |
2,850
| – | – | 0.01% | 230 |
|
|
2015
Q4 | $26K | Buy |
2,850
+600
| +27% | +$5.58K | 0.01% | 211 |
|
|
2015
Q3 | $40K | Hold |
2,250
| – | – | 0.02% | 180 |
|
|
2015
Q2 | $67K | Hold |
2,250
| – | – | 0.03% | 155 |
|
|
2015
Q1 | $50K | Hold |
2,250
| – | – | 0.02% | 176 |
|
|
2014
Q4 | $62K | Hold |
2,250
| – | – | 0.02% | 161 |
|
|
2014
Q3 | $44K | Buy |
2,250
+300
| +15% | +$5.5K | 0.02% | 184 |
|
|
2014
Q2 | $33K | Hold |
1,950
| – | – | 0.01% | 203 |
|
|
2014
Q1 | $28K | Buy |
1,950
+1,150
| +144% | +$15.5K | 0.01% | 215 |
|
|
2013
Q4 | $9K | Hold |
800
| – | – | ﹤0.01% | 301 |
|
|
2013
Q3 | $9K | Hold |
800
| – | – | ﹤0.01% | 288 |
|
|
2013
Q2 | $11K | Buy |
+800
| New | +$8.69K | ﹤0.01% | 277 |
|
Other funds holding EXAS
AIM
NAMA
American Research & Management Company's EXAS Position: Q3 2022 in Review
American Research & Management Company held its Exact Sciences (EXAS) position steady in Q3 2022 at 950 shares worth $31K. The position accounts for 0.01% of the portfolio, ranked #224.
American Research & Management Company first reported a position in EXAS in Q2 2013 and has held it in 38 quarters since. The position peaked at $126K in Q4 2020. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.
- American Research & Management Company held 950 shares of Exact Sciences worth $31K as of Q3 2022.
- American Research & Management Company left its Exact Sciences share count unchanged in Q3 2022.
- Exact Sciences made up 0.01% of American Research & Management Company's portfolio in Q3 2022, its #224 holding.
- American Research & Management Company first reported a position in Exact Sciences in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's Exact Sciences position peaked at $126K in Q4 2020.
- 480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.